NCT06440694View on ClinicalTrials.gov

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Venous Thromboembolism
Interventions
DRUG

Colchicine 0.5 mg po

Colchicine 0.5 mg po once daily for 180 days.

DRUG

Placebo 0.5 mg po

Placebo 0.5 mg po once daily for 180 days.

Trial Locations (1)

K1H 8L6

RECRUITING

The Ottawa Hospital General Campus, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER

NCT06440694 - Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) | Biotech Hunter | Biotech Hunter